_id
69171ba53c536f8df2316630
Ticker
TARS
Name
Tarsus Pharmaceuticals Inc
Exchange
NASDAQ
Address
15440 Laguna Canyon Road, Irvine, CA, United States, 92618
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.tarsusrx.com
Description
Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company's lead product candidate is XDEMVY, a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. It is also developing TP-04 for the treatment of Ocular Rosacea; TP-05 for potential Lyme disease prophylaxis; and community malaria reduction. In addition, the company develops lotilaner active pharmaceutical ingredient (API) to address diseases in human medicine, including eye care and infectious disease prevention. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.
Last Close
81.32
Volume
495273
Current Price
81.7
Change
0.46728971962618016
Last Updated
2025-12-04T13:52:59.851Z
Image
data:image/webp;base64,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
Ipo Date
2020-10-16T00:00:00.000Z
Market Cap
3475732480
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9643076923076923
Sentiment Sources
13
Rating
4.625
Target Price
86.1111
Strong Buy
6
Buy
1
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
118697000
Cost Of Revenue
24593000
Gross Profit
94104000
Operating Expenses
108633000
Operating Income
-14529000
Interest Expense
2268000
Pretax Income
-12585000
Net Income
-12585000
Eps
-0.29536902904232115
Dividends Per Share
-
Shares Outstanding
42449105
Income Tax Expense
-
EBITDA
-12125000
Operating Margin
-12.240410456877596
Total Other Income Expense Net
1944000
Cash
112724000
Short Term Investments
289113000
Receivables
74336000
Inventories
3836000
Total Current Assets
501704000
Property Plant Equipment
15979000
Total Assets
534561000
Payables
40642000
Short Term Debt
80000
Long Term Debt
72281000
Total Liabilities
199479000
Equity
335082000
Depreciation
400000
Change In Working Capital
19328000
Cash From Operations
18257000
Capital Expenditures
1910000
Cash From Investing
-4743000
Cash From Financing
2562000
Net Change In Cash
16076000
PE
-
PB
10.388652565342214
ROE
-3.755797088473866
ROA
-2.35426826872892
FCF
16347000
Fcf Percent
0.1377204141637952
Piotroski FScore
2
Health Score
35
Deep Value Investing Score
4.5
Defensive Investing Score
6.5
Dividend Investing Score
3
Economic Moat Investing Score
5.3
Garp Investing Score
4.5
Growth Investing Score
3.5
Momentum Investing Score
3
Net Net Investing Score
2.5
Quality Investing Score
4
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
118697000
Quarters > 0 > income Statement > cost Of Revenue
24593000
Quarters > 0 > income Statement > gross Profit
94104000
Quarters > 0 > income Statement > operating Expenses
108633000
Quarters > 0 > income Statement > operating Income
-14529000
Quarters > 0 > income Statement > interest Expense
2268000
Quarters > 0 > income Statement > pretax Income
-12585000
Quarters > 0 > income Statement > net Income
-12585000
Quarters > 0 > income Statement > eps
-0.29536902904232115
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
42607717
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-12125000
Quarters > 0 > income Statement > operating Margin
-12.240410456877596
Quarters > 0 > income Statement > total Other Income Expense Net
1944000
Quarters > 0 > balance Sheet > cash
112724000
Quarters > 0 > balance Sheet > short Term Investments
289113000
Quarters > 0 > balance Sheet > receivables
74336000
Quarters > 0 > balance Sheet > inventories
3836000
Quarters > 0 > balance Sheet > total Current Assets
501704000
Quarters > 0 > balance Sheet > property Plant Equipment
15979000
Quarters > 0 > balance Sheet > total Assets
534561000
Quarters > 0 > balance Sheet > payables
40642000
Quarters > 0 > balance Sheet > short Term Debt
80000
Quarters > 0 > balance Sheet > long Term Debt
72281000
Quarters > 0 > balance Sheet > total Liabilities
199479000
Quarters > 0 > balance Sheet > equity
335082000
Quarters > 0 > cash Flow > net Income
-12585000
Quarters > 0 > cash Flow > depreciation
400000
Quarters > 0 > cash Flow > change In Working Capital
19328000
Quarters > 0 > cash Flow > cash From Operations
18257000
Quarters > 0 > cash Flow > capital Expenditures
1910000
Quarters > 0 > cash Flow > cash From Investing
-4743000
Quarters > 0 > cash Flow > cash From Financing
2562000
Quarters > 0 > cash Flow > net Change In Cash
16076000
Quarters > 0 > ratios > PE
-0.29536902904232115
Quarters > 0 > ratios > PB
10.388652565342214
Quarters > 0 > ratios > ROE
-3.755797088473866
Quarters > 0 > ratios > ROA
-2.35426826872892
Quarters > 0 > ratios > FCF
16347000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.1377204141637952
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
102660000
Quarters > 1 > income Statement > cost Of Revenue
6237000
Quarters > 1 > income Statement > gross Profit
96423000
Quarters > 1 > income Statement > operating Expenses
118607000
Quarters > 1 > income Statement > operating Income
-22184000
Quarters > 1 > income Statement > interest Expense
2094000
Quarters > 1 > income Statement > pretax Income
-20340000
Quarters > 1 > income Statement > net Income
-20340000
Quarters > 1 > income Statement > eps
-0.48016484809935456
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
42360452
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-17647000
Quarters > 1 > income Statement > operating Margin
-21.60919540229885
Quarters > 1 > income Statement > total Other Income Expense Net
1844000
Quarters > 1 > balance Sheet > cash
96648000
Quarters > 1 > balance Sheet > short Term Investments
284495000
Quarters > 1 > balance Sheet > receivables
60240000
Quarters > 1 > balance Sheet > inventories
3873000
Quarters > 1 > balance Sheet > total Current Assets
474429000
Quarters > 1 > balance Sheet > property Plant Equipment
3411000
Quarters > 1 > balance Sheet > total Assets
494994000
Quarters > 1 > balance Sheet > payables
28075000
Quarters > 1 > balance Sheet > short Term Debt
317000
Quarters > 1 > balance Sheet > long Term Debt
72129000
Quarters > 1 > balance Sheet > total Liabilities
162382000
Quarters > 1 > balance Sheet > equity
332612000
Quarters > 1 > cash Flow > net Income
-20340000
Quarters > 1 > cash Flow > depreciation
453000
Quarters > 1 > cash Flow > change In Working Capital
-16355000
Quarters > 1 > cash Flow > cash From Operations
-29387000
Quarters > 1 > cash Flow > capital Expenditures
1001000
Quarters > 1 > cash Flow > cash From Investing
-51704000
Quarters > 1 > cash Flow > cash From Financing
1952000
Quarters > 1 > cash Flow > net Change In Cash
-79139000
Quarters > 1 > ratios > PE
-0.48016484809935456
Quarters > 1 > ratios > PB
10.405063342272678
Quarters > 1 > ratios > ROE
-6.115233365001864
Quarters > 1 > ratios > ROA
-4.1091407168571745
Quarters > 1 > ratios > FCF
-30388000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-0.29600623417105004
Quarters > 1 > health Score
26
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
78335000
Quarters > 2 > income Statement > cost Of Revenue
5211000
Quarters > 2 > income Statement > gross Profit
73124000
Quarters > 2 > income Statement > operating Expenses
99404000
Quarters > 2 > income Statement > operating Income
-26280000
Quarters > 2 > income Statement > interest Expense
2074000
Quarters > 2 > income Statement > pretax Income
-25120000
Quarters > 2 > income Statement > net Income
-25120000
Quarters > 2 > income Statement > eps
-0.6384488701704311
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
39345359
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-22447000
Quarters > 2 > income Statement > operating Margin
-33.548222378247274
Quarters > 2 > income Statement > total Other Income Expense Net
1160000
Quarters > 2 > balance Sheet > cash
175787000
Quarters > 2 > balance Sheet > short Term Investments
232129000
Quarters > 2 > balance Sheet > receivables
64153000
Quarters > 2 > balance Sheet > inventories
2705000
Quarters > 2 > balance Sheet > total Current Assets
480773000
Quarters > 2 > balance Sheet > property Plant Equipment
3180000
Quarters > 2 > balance Sheet > total Assets
500750000
Quarters > 2 > balance Sheet > payables
28383000
Quarters > 2 > balance Sheet > short Term Debt
384000
Quarters > 2 > balance Sheet > long Term Debt
71984000
Quarters > 2 > balance Sheet > total Liabilities
158292000
Quarters > 2 > balance Sheet > equity
342458000
Quarters > 2 > cash Flow > net Income
-25120000
Quarters > 2 > cash Flow > depreciation
460000
Quarters > 2 > cash Flow > change In Working Capital
-1910000
Quarters > 2 > cash Flow > cash From Operations
-20651000
Quarters > 2 > cash Flow > capital Expenditures
590000
Quarters > 2 > cash Flow > cash From Investing
-34942000
Quarters > 2 > cash Flow > cash From Financing
136562000
Quarters > 2 > cash Flow > net Change In Cash
80969000
Quarters > 2 > ratios > PE
-0.6384488701704311
Quarters > 2 > ratios > PB
9.386598737071408
Quarters > 2 > ratios > ROE
-7.3352060690654035
Quarters > 2 > ratios > ROA
-5.0164752870693965
Quarters > 2 > ratios > FCF
-21241000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.2711559328524925
Quarters > 2 > health Score
27
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
66408000
Quarters > 3 > income Statement > cost Of Revenue
4926000
Quarters > 3 > income Statement > gross Profit
61482000
Quarters > 3 > income Statement > operating Expenses
85903000
Quarters > 3 > income Statement > operating Income
-24421000
Quarters > 3 > income Statement > interest Expense
2174000
Quarters > 3 > income Statement > pretax Income
-23113000
Quarters > 3 > income Statement > net Income
-23113000
Quarters > 3 > income Statement > eps
-0.5993894282621516
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
38560907
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-20369000
Quarters > 3 > income Statement > operating Margin
-36.7741838332731
Quarters > 3 > income Statement > total Other Income Expense Net
1308000
Quarters > 3 > balance Sheet > cash
94819000
Quarters > 3 > balance Sheet > short Term Investments
196557000
Quarters > 3 > balance Sheet > receivables
48059000
Quarters > 3 > balance Sheet > inventories
2620000
Quarters > 3 > balance Sheet > total Current Assets
356705000
Quarters > 3 > balance Sheet > property Plant Equipment
2866000
Quarters > 3 > balance Sheet > total Assets
376991000
Quarters > 3 > balance Sheet > payables
27739000
Quarters > 3 > balance Sheet > short Term Debt
608000
Quarters > 3 > balance Sheet > long Term Debt
71845000
Quarters > 3 > balance Sheet > total Liabilities
152457000
Quarters > 3 > balance Sheet > equity
224534000
Quarters > 3 > cash Flow > net Income
-23113000
Quarters > 3 > cash Flow > depreciation
432000
Quarters > 3 > cash Flow > change In Working Capital
-5727000
Quarters > 3 > cash Flow > cash From Operations
-22182000
Quarters > 3 > cash Flow > capital Expenditures
5072000
Quarters > 3 > cash Flow > cash From Investing
-59574000
Quarters > 3 > cash Flow > cash From Financing
2927000
Quarters > 3 > cash Flow > net Change In Cash
-78829000
Quarters > 3 > ratios > PE
-0.5993894282621516
Quarters > 3 > ratios > PB
14.03095344981161
Quarters > 3 > ratios > ROE
-10.293763973384877
Quarters > 3 > ratios > ROA
-6.130915592149415
Quarters > 3 > ratios > FCF
-27254000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.41040236116130585
Quarters > 3 > health Score
23
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
182953000
Annuals > 0 > income Statement > cost Of Revenue
12826000
Annuals > 0 > income Statement > gross Profit
170127000
Annuals > 0 > income Statement > operating Expenses
290696000
Annuals > 0 > income Statement > operating Income
-120569000
Annuals > 0 > income Statement > interest Expense
7447000
Annuals > 0 > income Statement > pretax Income
-115554000
Annuals > 0 > income Statement > net Income
-115554000
Annuals > 0 > income Statement > eps
-3.0728738111341776
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
37604538
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-106480000
Annuals > 0 > income Statement > operating Margin
-65.90162500751559
Annuals > 0 > income Statement > total Other Income Expense Net
5015000
Annuals > 0 > balance Sheet > cash
94819000
Annuals > 0 > balance Sheet > short Term Investments
196557000
Annuals > 0 > balance Sheet > receivables
48059000
Annuals > 0 > balance Sheet > inventories
2620000
Annuals > 0 > balance Sheet > total Current Assets
356705000
Annuals > 0 > balance Sheet > property Plant Equipment
2866000
Annuals > 0 > balance Sheet > total Assets
376991000
Annuals > 0 > balance Sheet > payables
27739000
Annuals > 0 > balance Sheet > short Term Debt
608000
Annuals > 0 > balance Sheet > long Term Debt
71845000
Annuals > 0 > balance Sheet > total Liabilities
152457000
Annuals > 0 > balance Sheet > equity
224534000
Annuals > 0 > cash Flow > net Income
-115554000
Annuals > 0 > cash Flow > depreciation
1225000
Annuals > 0 > cash Flow > change In Working Capital
3844000
Annuals > 0 > cash Flow > cash From Operations
-83027000
Annuals > 0 > cash Flow > capital Expenditures
1567000
Annuals > 0 > cash Flow > cash From Investing
-199195000
Annuals > 0 > cash Flow > cash From Financing
154656000
Annuals > 0 > cash Flow > net Change In Cash
-127566000
Annuals > 0 > ratios > PE
-3.0728738111341776
Annuals > 0 > ratios > PB
13.71311058209447
Annuals > 0 > ratios > ROE
-51.463920831588986
Annuals > 0 > ratios > ROA
-30.65166011920709
Annuals > 0 > ratios > FCF
-84594000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-0.46238104868463487
Annuals > 0 > health Score
23
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
17447000
Annuals > 1 > income Statement > cost Of Revenue
1593000
Annuals > 1 > income Statement > gross Profit
15854000
Annuals > 1 > income Statement > operating Expenses
159012000
Annuals > 1 > income Statement > operating Income
-143158000
Annuals > 1 > income Statement > interest Expense
3225000
Annuals > 1 > income Statement > pretax Income
-135893000
Annuals > 1 > income Statement > net Income
-135893000
Annuals > 1 > income Statement > eps
-4.624841695663887
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
29383276
Annuals > 1 > income Statement > income Tax Expense
709105
Annuals > 1 > income Statement > EBITDA
-131670000
Annuals > 1 > income Statement > operating Margin
-820.5307502722532
Annuals > 1 > income Statement > total Other Income Expense Net
7265000
Annuals > 1 > balance Sheet > cash
224947000
Annuals > 1 > balance Sheet > short Term Investments
2495000
Annuals > 1 > balance Sheet > receivables
17714000
Annuals > 1 > balance Sheet > inventories
3107000
Annuals > 1 > balance Sheet > total Current Assets
256131000
Annuals > 1 > balance Sheet > property Plant Equipment
3348000
Annuals > 1 > balance Sheet > total Assets
265491000
Annuals > 1 > balance Sheet > payables
17772000
Annuals > 1 > balance Sheet > short Term Debt
398000
Annuals > 1 > balance Sheet > long Term Debt
29819000
Annuals > 1 > balance Sheet > total Liabilities
68503000
Annuals > 1 > balance Sheet > equity
196988000
Annuals > 1 > cash Flow > net Income
-135893000
Annuals > 1 > cash Flow > depreciation
877000
Annuals > 1 > cash Flow > change In Working Capital
306000
Annuals > 1 > cash Flow > cash From Operations
-117493000
Annuals > 1 > cash Flow > capital Expenditures
5502000
Annuals > 1 > cash Flow > cash From Investing
140604000
Annuals > 1 > cash Flow > cash From Financing
130176000
Annuals > 1 > cash Flow > net Change In Cash
153287000
Annuals > 1 > ratios > PE
-4.624841695663887
Annuals > 1 > ratios > PB
12.213447717018296
Annuals > 1 > ratios > ROE
-68.98542043170143
Annuals > 1 > ratios > ROA
-51.18553924615147
Annuals > 1 > ratios > FCF
-122995000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-7.049636040580042
Annuals > 1 > health Score
26
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
25816000
Annuals > 2 > income Statement > cost Of Revenue
955000
Annuals > 2 > income Statement > gross Profit
24861000
Annuals > 2 > income Statement > operating Expenses
87573000
Annuals > 2 > income Statement > operating Income
-62712000
Annuals > 2 > income Statement > interest Expense
2064000
Annuals > 2 > income Statement > pretax Income
-62095000
Annuals > 2 > income Statement > net Income
-62091000
Annuals > 2 > income Statement > eps
-2.522004736044712
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
24619700
Annuals > 2 > income Statement > income Tax Expense
-4000
Annuals > 2 > income Statement > EBITDA
-59705000
Annuals > 2 > income Statement > operating Margin
-242.91911992562754
Annuals > 2 > income Statement > total Other Income Expense Net
617000
Annuals > 2 > balance Sheet > cash
71660000
Annuals > 2 > balance Sheet > short Term Investments
145366000
Annuals > 2 > balance Sheet > receivables
3582000
Annuals > 2 > balance Sheet > inventories
4762233
Annuals > 2 > balance Sheet > total Current Assets
225375000
Annuals > 2 > balance Sheet > property Plant Equipment
1532000
Annuals > 2 > balance Sheet > total Assets
227863000
Annuals > 2 > balance Sheet > payables
5498000
Annuals > 2 > balance Sheet > short Term Debt
721000
Annuals > 2 > balance Sheet > long Term Debt
19434000
Annuals > 2 > balance Sheet > total Liabilities
34963000
Annuals > 2 > balance Sheet > equity
192900000
Annuals > 2 > cash Flow > net Income
-62091000
Annuals > 2 > cash Flow > depreciation
325000
Annuals > 2 > cash Flow > change In Working Capital
-951000
Annuals > 2 > cash Flow > cash From Operations
-49030000
Annuals > 2 > cash Flow > capital Expenditures
506000
Annuals > 2 > cash Flow > cash From Investing
-144629000
Annuals > 2 > cash Flow > cash From Financing
93987000
Annuals > 2 > cash Flow > net Change In Cash
-99672000
Annuals > 2 > ratios > PE
-2.522004736044712
Annuals > 2 > ratios > PB
10.450290492483152
Annuals > 2 > ratios > ROE
-32.18818040435459
Annuals > 2 > ratios > ROA
-27.249268200629324
Annuals > 2 > ratios > FCF
-49536000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1.9188100402850945
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
57027000
Annuals > 3 > income Statement > cost Of Revenue
2075000
Annuals > 3 > income Statement > gross Profit
54952000
Annuals > 3 > income Statement > operating Expenses
67109000
Annuals > 3 > income Statement > operating Income
-12157000
Annuals > 3 > income Statement > interest Expense
2881000
Annuals > 3 > income Statement > pretax Income
-13772000
Annuals > 3 > income Statement > net Income
-13827000
Annuals > 3 > income Statement > eps
-0.6727129583869601
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
20554086
Annuals > 3 > income Statement > income Tax Expense
55000
Annuals > 3 > income Statement > EBITDA
-13460000
Annuals > 3 > income Statement > operating Margin
-21.317972188612412
Annuals > 3 > income Statement > total Other Income Expense Net
-1615000
Annuals > 3 > balance Sheet > cash
171332000
Annuals > 3 > balance Sheet > short Term Investments
483000
Annuals > 3 > balance Sheet > receivables
92000
Annuals > 3 > balance Sheet > inventories
175684140
Annuals > 3 > balance Sheet > total Current Assets
175952000
Annuals > 3 > balance Sheet > property Plant Equipment
1829000
Annuals > 3 > balance Sheet > total Assets
178907000
Annuals > 3 > balance Sheet > payables
2856000
Annuals > 3 > balance Sheet > short Term Debt
1306000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
12177000
Annuals > 3 > balance Sheet > equity
166730000
Annuals > 3 > cash Flow > net Income
-13827000
Annuals > 3 > cash Flow > depreciation
312000
Annuals > 3 > cash Flow > change In Working Capital
1372000
Annuals > 3 > cash Flow > cash From Operations
3748000
Annuals > 3 > cash Flow > capital Expenditures
586000
Annuals > 3 > cash Flow > cash From Investing
-586000
Annuals > 3 > cash Flow > cash From Financing
21000
Annuals > 3 > cash Flow > net Change In Cash
3183000
Annuals > 3 > ratios > PE
-0.6727129583869601
Annuals > 3 > ratios > PB
10.093975659329454
Annuals > 3 > ratios > ROE
-8.293048641516224
Annuals > 3 > ratios > ROA
-7.728596421604521
Annuals > 3 > ratios > FCF
3162000
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
0.05544741964332685
Annuals > 3 > health Score
31
Valuation > metrics > PE
-0.29536902904232115
Valuation > metrics > PB
10.388652565342214
Valuation > final Score
20
Valuation > verdict
246.3% Overvalued
Profitability > metrics > ROE
-3.755797088473866
Profitability > metrics > ROA
-2.5084511983161386
Profitability > metrics > Net Margin
-0.10602626856618112
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.5953139828459899
Risk > metrics > Interest Coverage
-6.406084656084656
Risk > final Score
22
Risk > verdict
High
Liquidity > metrics > Current Ratio
12.320220028485831
Liquidity > metrics > Quick Ratio
12.226020332989538
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
18
Prev Risks > 1
9
Prev Risks > 2
3
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-12T01:10:19.963Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-05
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.3
Earnings History > 0 > eps Estimate
-0.3645
Earnings History > 0 > eps Difference
0.0645
Earnings History > 0 > surprise Percent
17.6955
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-06
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.48
Earnings History > 1 > eps Estimate
-0.38
Earnings History > 1 > eps Difference
-0.1
Earnings History > 1 > surprise Percent
-26.3158
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-06
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.64
Earnings History > 2 > eps Estimate
-0.63
Earnings History > 2 > eps Difference
-0.01
Earnings History > 2 > surprise Percent
-1.5873
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-25
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.6
Earnings History > 3 > eps Estimate
-0.8157
Earnings History > 3 > eps Difference
0.2157
Earnings History > 3 > surprise Percent
26.4435
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-07
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.61
Earnings History > 4 > eps Estimate
-0.94
Earnings History > 4 > eps Difference
0.33
Earnings History > 4 > surprise Percent
35.1064
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.88
Earnings History > 5 > eps Estimate
-0.92
Earnings History > 5 > eps Difference
0.04
Earnings History > 5 > surprise Percent
4.3478
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-08
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-1.01
Earnings History > 6 > eps Estimate
-1.2
Earnings History > 6 > eps Difference
0.19
Earnings History > 6 > surprise Percent
15.8333
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-27
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-1.31
Earnings History > 7 > eps Estimate
-1.36
Earnings History > 7 > eps Difference
0.05
Earnings History > 7 > surprise Percent
3.6765
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-09
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-1.28
Earnings History > 8 > eps Estimate
-1.37
Earnings History > 8 > eps Difference
0.09
Earnings History > 8 > surprise Percent
6.5693
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-1.17
Earnings History > 9 > eps Estimate
-1.08
Earnings History > 9 > eps Difference
-0.09
Earnings History > 9 > surprise Percent
-8.3333
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-09
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.88
Earnings History > 10 > eps Estimate
-0.94
Earnings History > 10 > eps Difference
0.06
Earnings History > 10 > surprise Percent
6.383
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-13
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.49
Earnings History > 11 > eps Estimate
-0.69
Earnings History > 11 > eps Difference
0.2
Earnings History > 11 > surprise Percent
28.9855
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-09
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.84
Earnings History > 12 > eps Estimate
-0.97
Earnings History > 12 > eps Difference
0.13
Earnings History > 12 > surprise Percent
13.4021
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-11
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.24
Earnings History > 13 > eps Estimate
-0.59
Earnings History > 13 > eps Difference
0.35
Earnings History > 13 > surprise Percent
59.322
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-10
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.98
Earnings History > 14 > eps Estimate
-0.92
Earnings History > 14 > eps Difference
-0.06
Earnings History > 14 > surprise Percent
-6.5217
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-14
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.72
Earnings History > 15 > eps Estimate
-0.73
Earnings History > 15 > eps Difference
0.01
Earnings History > 15 > surprise Percent
1.3699
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-09
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.76
Earnings History > 16 > eps Estimate
-0.43
Earnings History > 16 > eps Difference
-0.33
Earnings History > 16 > surprise Percent
-76.7442
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-04
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
0.33
Earnings History > 17 > eps Estimate
-0.48
Earnings History > 17 > eps Difference
0.81
Earnings History > 17 > surprise Percent
168.75
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-11
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
0.47
Earnings History > 18 > eps Estimate
-0.64
Earnings History > 18 > eps Difference
1.11
Earnings History > 18 > surprise Percent
173.4375
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-31
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.68
Earnings History > 19 > eps Estimate
-0.66
Earnings History > 19 > eps Difference
-0.02
Earnings History > 19 > surprise Percent
-3.0303
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-24
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-3.71
Earnings History > 20 > eps Estimate
-0.5
Earnings History > 20 > eps Difference
-3.21
Earnings History > 20 > surprise Percent
-642
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-09-02
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.1949
Earnings History > 21 > eps Estimate
-0.46
Earnings History > 21 > eps Difference
0.2651
Earnings History > 21 > surprise Percent
57.6304
Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company's lead product candidate is XDEMVY, a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. It is also developing TP-04 for the treatment of Ocular Rosacea; TP-05 for potential Lyme disease prophylaxis; and community malaria reduction. In addition, the company develops lotilaner active pharmaceutical ingredient (API) to address diseases in human medicine, including eye care and infectious disease prevention. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ABarclays Initiates Coverage on Tarsus Pharmaceuticals (TARS) with Overweight Rating | TARS Stock News GuruFocus
Read more →Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Rating of “Moderate Buy” by Analysts Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$86.1111
Analyst Picks
Strong Buy
6
Buy
1
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Medium
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 98.50% of the total shares of Tarsus Pharmaceuticals Inc
1.
BlackRock Inc(8.9832%)
since
2025/06/30
2.
RTW INVESTMENTS, LLC(7.3712%)
since
2025/06/30
3.
Paradigm Biocapital Advisors LP(7.05%)
since
2025/06/30
4.
Jennison Associates LLC(5.8464%)
since
2025/06/30
5.
TANG CAPITAL MANAGEMENT LLC(5.8151%)
since
2025/06/30
6.
Vanguard Group Inc(5.4421%)
since
2025/06/30
7.
Morgan Stanley - Brokerage Accounts(4.8697%)
since
2025/06/30
8.
HHG PLC(4.2804%)
since
2025/06/30
9.
Deep Track Capital, LP(4.1455%)
since
2025/06/30
10.
Vanguard Total Stock Mkt Idx Inv(2.8181%)
since
2025/07/31
11.
The Toronto-Dominion Bank(2.3735%)
since
2025/06/30
12.
Assenagon Asset Management SA(2.3632%)
since
2025/06/30
13.
Lord, Abbett & Co LLC(2.358%)
since
2025/06/30
14.
State Street Corp(2.3236%)
since
2025/06/30
15.
Macquarie Group Ltd(2.2477%)
since
2025/06/30
16.
Geode Capital Management, LLC(2.2135%)
since
2025/06/30
17.
iShares Russell 2000 ETF(2.21%)
since
2025/08/31
18.
Amvescap Plc.(2.1995%)
since
2025/06/30
19.
Driehaus Capital Management LLC(2.0764%)
since
2025/06/30
20.
D. E. Shaw & Co LP(1.7131%)
since
2025/06/30
21.
Jennison SMid Cap Core Equity(1.6174%)
since
2025/06/30
22.
PGIM Jennison Small Company A(1.6174%)
since
2025/07/31
23.
Adage Capital Partners Gp LLC(1.2863%)
since
2025/06/30
24.
Artisan Partners Limited Partnership(1.2775%)
since
2025/06/30
25.
MEDICAL BioHealth EUR Acc(1.2502%)
since
2025/06/30
26.
Macquarie Small Cap Growth C(1.1328%)
since
2025/07/31
27.
Vanguard Institutional Extnd Mkt Idx Tr(0.9795%)
since
2025/07/31
28.
Lord Abbett Developing Growth A(0.9624%)
since
2025/06/30
29.
RTW Biotech Opportunities Ord(0.9506%)
since
2024/12/31
30.
Fidelity Small Cap Index(0.922%)
since
2025/06/30
31.
Jennison Health Sciences Equity(0.9067%)
since
2025/06/30
32.
PGIM Jennison Health Sciences Z(0.9067%)
since
2025/07/31
33.
Artisan International Small-Mid Investor(0.8489%)
since
2025/06/30
34.
Artisan Non-U.S. Small-Mid Growth Comp(0.8489%)
since
2025/06/30
35.
iShares Russell 2000 Growth ETF(0.8068%)
since
2025/08/31
36.
Janus Henderson Global Life Sciences(0.7644%)
since
2025/06/30
37.
Janus Henderson Global Life Sciences D(0.7644%)
since
2025/06/30
38.
Invesco Main Street Small Cap R6(0.6575%)
since
2025/07/31
39.
APO Medical Opportunities R(0.6545%)
since
2025/07/31
40.
Invesco Small Cap Core(0.6464%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.3
EPS Estimate
-0.3645
EPS Difference
0.0645
Surprise Percent
17.6955%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.